These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32439865)

  • 21. Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity.
    Dravis C; Chung CY; Lytle NK; Herrera-Valdez J; Luna G; Trejo CL; Reya T; Wahl GM
    Cancer Cell; 2018 Sep; 34(3):466-482.e6. PubMed ID: 30174241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast Cancer: Multiple Subtypes within a Tumor?
    Yeo SK; Guan JL
    Trends Cancer; 2017 Nov; 3(11):753-760. PubMed ID: 29120751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
    Dadhania V; Zhang M; Zhang L; Bondaruk J; Majewski T; Siefker-Radtke A; Guo CC; Dinney C; Cogdell DE; Zhang S; Lee S; Lee JG; Weinstein JN; Baggerly K; McConkey D; Czerniak B
    EBioMedicine; 2016 Oct; 12():105-117. PubMed ID: 27612592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes.
    Wang L; Smith BA; Balanis NG; Tsai BL; Nguyen K; Cheng MW; Obusan MB; Esedebe FN; Patel SJ; Zhang H; Clark PM; Sisk AE; Said JW; Huang J; Graeber TG; Witte ON; Chin AI; Park JW
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):563-572. PubMed ID: 31871155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.
    Roudnicky F; Dieterich LC; Poyet C; Buser L; Wild P; Tang D; Camenzind P; Ho CH; Otto VI; Detmar M
    J Pathol; 2017 Jun; 242(2):193-205. PubMed ID: 28295307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.
    Morera DS; Hasanali SL; Belew D; Ghosh S; Klaassen Z; Jordan AR; Wang J; Terris MK; Bollag RJ; Merseburger AS; Stenzl A; Soloway MS; Lokeshwar VB
    J Urol; 2020 Jan; 203(1):62-72. PubMed ID: 31112107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
    Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cells isolated from residual intracranial tumors after treatment express iPSC genes and possess neural lineage differentiation plasticity.
    Palanichamy K; Jacob JR; Litzenberg KT; Ray-Chaudhury A; Chakravarti A
    EBioMedicine; 2018 Oct; 36():281-292. PubMed ID: 30269995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic subtypes of invasive bladder cancer.
    McConkey DJ; Choi W; Dinney CP
    Curr Opin Urol; 2015 Sep; 25(5):449-58. PubMed ID: 26218634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells.
    Jou YC; Wang SC; Dai YC; Chen SY; Shen CH; Lee YR; Chen LC; Liu YW
    Oncol Rep; 2019 Sep; 42(3):1005-1016. PubMed ID: 31322264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].
    Gaisa NT
    Pathologe; 2016 Nov; 37(Suppl 2):196-203. PubMed ID: 27613302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.
    Mokkapati S; Porten SP; Narayan VM; Lim AH; Jayaratna IS; Roth B; Cheng T; Navai N; Wszolek M; Melquist J; Manyam G; Choi W; Broom B; Pretzsch S; Czerniak B; McConkey DJ; Dinney CPN
    Mol Cancer Res; 2020 Jun; 18(6):811-821. PubMed ID: 32122956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular Origins and Lineage Plasticity in Cancer.
    Pitarresi JR; Stanger BZ
    Cold Spring Harb Perspect Med; 2024 Jun; 14(6):. PubMed ID: 37604590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive Gene Expression Analyses of Immunohistochemically Defined Subgroups of Muscle-Invasive Urinary Bladder Urothelial Carcinoma.
    Kim B; Jang I; Kim K; Jung M; Lee C; Park JH; Kim YA; Moon KC
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
    Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
    J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased urothelial cell detection in the primary bladder smooth muscle cell cultures with dual MACS/qRT-PCR approach.
    Genheimer CW; Guthrie KI; Shokes JE; Bruce AT; Quinlan SF; Sangha N; Ilagan RM; Basu J; Burnette T; Ludlow JW
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):184-9. PubMed ID: 20930617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.
    Chakravarthi BVSK; Rodriguez Pena MDC; Agarwal S; Chandrashekar DS; Hodigere Balasubramanya SA; Jabboure FJ; Matoso A; Bivalacqua TJ; Rezaei K; Chaux A; Grizzle WE; Sonpavde G; Gordetsky J; Netto GJ; Varambally S
    Neoplasia; 2018 Sep; 20(9):894-904. PubMed ID: 30121007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of a High-Plasticity Cell State during Lung Cancer Evolution.
    Marjanovic ND; Hofree M; Chan JE; Canner D; Wu K; Trakala M; Hartmann GG; Smith OC; Kim JY; Evans KV; Hudson A; Ashenberg O; Porter CBM; Bejnood A; Subramanian A; Pitter K; Yan Y; Delorey T; Phillips DR; Shah N; Chaudhary O; Tsankov A; Hollmann T; Rekhtman N; Massion PP; Poirier JT; Mazutis L; Li R; Lee JH; Amon A; Rudin CM; Jacks T; Regev A; Tammela T
    Cancer Cell; 2020 Aug; 38(2):229-246.e13. PubMed ID: 32707077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A zinc finger protein gene signature enables bladder cancer treatment stratification.
    Zhang J; Zhang C; Cao P; Zheng X; Yu B; Cao H; Gao Z; Zhang F; Wu J; Cao H; Hao C; Sun Z; Wang W
    Aging (Albany NY); 2021 May; 13(9):13023-13038. PubMed ID: 33962398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.